1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. Germany >
  6. Riemser Arzneimittel AG >
  7. M&A

Riemser Arzneimittel AG Mergers & Acquisitions

Riemser Arzneimittel AG M&A Summary

Riemser Arzneimittel AG has acquired 2 companies of its own.

Riemser Arzneimittel AG has acquired in 2 countries. The Company’s most targeted sectors include leisure (50%) and medical products (50%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Riemser Arzneimittel AG

An der Wiek 7,
Greifswald - Insel Riems, 17493
Germany,
+49 30 338427-0
www.riemser.de

All (2) Buy (2) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2019-10-02 Zaltanpharma Laboratories · Leisure
Madrid, Spain · www.zaltanpharma.com

Zaltanpharma Laboratories is a pharmaceutical company focused on providing multichannel marketing and distribution of own pharmaceutical products and product promotion of other laboratories. Zaltanpharma was formed in 2017 and is based in Madrid, Spain.

- Divestiture

Riemser Arzneimittel AG

icon Group


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal